Kaur et al. (2012) found that PTPN11/SHP2 was extremely highly expressed in GCs in patients with polycystic ovarian syndrome, who exhibited hyperandrogenism and aberrant folliculogenesis, suggesting that SHP2 in GCs may be involved in the regulation of follicular development. This evidence concerns the gene PTPN11 and hyperandrogenism.